Identification of viable myocardium by dipyridamole-induced improvement in regional left ventricular function assessed by echocardiography in myocardial infarction and comparison with thallium scintigraphy at rest

Eugenio Picano, Paolo Marzullo, Guido Gigli, Barbara Reisenhofer, Oberdan Parodi, Alessandro Distante, Antonio L'Abbate

Research output: Contribution to journalArticle

Abstract

In patients with coronary artery disease and left ventricular impairment, the distinction between ventricular dysfunction due to myocardial fibrosis and postischemic, viable, although dyssynergic, myocardium has important clinical implications. Experimental studies have shown that dipyridamole can increase myocardial function in stunned segments, outlining a potential role of dipyridamole-induced functional recovery as an ultrasonic marker of myocardial viability. The aim of this study was to assess whether the increase of regional left ventricular function early during dipyridamole infusion in basally asynergic segments could identify viable myocardium recognized by rest injected, delayed (>14 hours from tracer injection) thallium and (in a subset of patients) late functional recovery evaluated by a follow-up echocardiogram at rest. Twenty-two patients with angiographically documented coronary artery disease and regional dysfunction in resting conditions (average left ventricular ejection fraction 43 ± 8%) were studied by echocardiography. All patients underwent a dipyridamole-echocardiographic test (up to 0.84 mg/kg over 10 minutes) and a delayed planar thallium study. A 13-segment model was used for both techniques. A score index ranging from 1 (normokinesia) to 4 (dyskinesia) was used for echocardiography. Thallium-201 activity was expressed in each segment as the percentage of maximal activity in the corresponding view. After dipyridamole, the wall motion score was assigned to each segment in resting conditions and at peak hyperkinesia before possible mechanical signs of ischemia. A segment was considered viable when there was a regional activity >55% of peak thallium and when a resting dyssynergy (echocardiographic score ≥2) showed an improvement of ≥1 grade by dipyridamole. In all, 80 basally asynergic segments were scored. Dipyridamole and thallium had concordant results in 21 of 26 thallium-viable and 52 of 54 thallium-necrotic segments. The 23 segments viable by dipyridamole had a higher thallium score than did the 57 necrotic by dipyridamole (73 ± 9 vs 42 ± 9; p <0.01). In a subset of 15 patients, a follow-up echocardiogram at rest was obtained at 3.4 ± 2.7 months after the initial study. A significant functional recovery (improvement of ≥1 grade) was found in 15 of 19 segments with and only 5 of 39 without dipyridamole-induced improvement (79 vs 13%; p <0.01). These observations suggest that dipyridamole-induced recovery in the contractile function of basally asynergic segments (possibly linked to the inotropic effect of increased flow) identifies areas with myocardial viability.

Original languageEnglish
Pages (from-to)703-710
Number of pages8
JournalThe American Journal of Cardiology
Volume70
Issue number7
DOIs
Publication statusPublished - Sep 15 1992

Fingerprint

Dipyridamole
Thallium
Left Ventricular Function
Radionuclide Imaging
Echocardiography
Myocardium
Myocardial Infarction
Coronary Artery Disease
Hyperkinesis
Ventricular Dysfunction
Dyskinesias
Ultrasonics
Stroke Volume
Fibrosis
Ischemia

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Identification of viable myocardium by dipyridamole-induced improvement in regional left ventricular function assessed by echocardiography in myocardial infarction and comparison with thallium scintigraphy at rest. / Picano, Eugenio; Marzullo, Paolo; Gigli, Guido; Reisenhofer, Barbara; Parodi, Oberdan; Distante, Alessandro; L'Abbate, Antonio.

In: The American Journal of Cardiology, Vol. 70, No. 7, 15.09.1992, p. 703-710.

Research output: Contribution to journalArticle

@article{e45ce5288c714f2581ea788a256a1ea3,
title = "Identification of viable myocardium by dipyridamole-induced improvement in regional left ventricular function assessed by echocardiography in myocardial infarction and comparison with thallium scintigraphy at rest",
abstract = "In patients with coronary artery disease and left ventricular impairment, the distinction between ventricular dysfunction due to myocardial fibrosis and postischemic, viable, although dyssynergic, myocardium has important clinical implications. Experimental studies have shown that dipyridamole can increase myocardial function in stunned segments, outlining a potential role of dipyridamole-induced functional recovery as an ultrasonic marker of myocardial viability. The aim of this study was to assess whether the increase of regional left ventricular function early during dipyridamole infusion in basally asynergic segments could identify viable myocardium recognized by rest injected, delayed (>14 hours from tracer injection) thallium and (in a subset of patients) late functional recovery evaluated by a follow-up echocardiogram at rest. Twenty-two patients with angiographically documented coronary artery disease and regional dysfunction in resting conditions (average left ventricular ejection fraction 43 ± 8{\%}) were studied by echocardiography. All patients underwent a dipyridamole-echocardiographic test (up to 0.84 mg/kg over 10 minutes) and a delayed planar thallium study. A 13-segment model was used for both techniques. A score index ranging from 1 (normokinesia) to 4 (dyskinesia) was used for echocardiography. Thallium-201 activity was expressed in each segment as the percentage of maximal activity in the corresponding view. After dipyridamole, the wall motion score was assigned to each segment in resting conditions and at peak hyperkinesia before possible mechanical signs of ischemia. A segment was considered viable when there was a regional activity >55{\%} of peak thallium and when a resting dyssynergy (echocardiographic score ≥2) showed an improvement of ≥1 grade by dipyridamole. In all, 80 basally asynergic segments were scored. Dipyridamole and thallium had concordant results in 21 of 26 thallium-viable and 52 of 54 thallium-necrotic segments. The 23 segments viable by dipyridamole had a higher thallium score than did the 57 necrotic by dipyridamole (73 ± 9 vs 42 ± 9; p <0.01). In a subset of 15 patients, a follow-up echocardiogram at rest was obtained at 3.4 ± 2.7 months after the initial study. A significant functional recovery (improvement of ≥1 grade) was found in 15 of 19 segments with and only 5 of 39 without dipyridamole-induced improvement (79 vs 13{\%}; p <0.01). These observations suggest that dipyridamole-induced recovery in the contractile function of basally asynergic segments (possibly linked to the inotropic effect of increased flow) identifies areas with myocardial viability.",
author = "Eugenio Picano and Paolo Marzullo and Guido Gigli and Barbara Reisenhofer and Oberdan Parodi and Alessandro Distante and Antonio L'Abbate",
year = "1992",
month = "9",
day = "15",
doi = "10.1016/0002-9149(92)90545-A",
language = "English",
volume = "70",
pages = "703--710",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "7",

}

TY - JOUR

T1 - Identification of viable myocardium by dipyridamole-induced improvement in regional left ventricular function assessed by echocardiography in myocardial infarction and comparison with thallium scintigraphy at rest

AU - Picano, Eugenio

AU - Marzullo, Paolo

AU - Gigli, Guido

AU - Reisenhofer, Barbara

AU - Parodi, Oberdan

AU - Distante, Alessandro

AU - L'Abbate, Antonio

PY - 1992/9/15

Y1 - 1992/9/15

N2 - In patients with coronary artery disease and left ventricular impairment, the distinction between ventricular dysfunction due to myocardial fibrosis and postischemic, viable, although dyssynergic, myocardium has important clinical implications. Experimental studies have shown that dipyridamole can increase myocardial function in stunned segments, outlining a potential role of dipyridamole-induced functional recovery as an ultrasonic marker of myocardial viability. The aim of this study was to assess whether the increase of regional left ventricular function early during dipyridamole infusion in basally asynergic segments could identify viable myocardium recognized by rest injected, delayed (>14 hours from tracer injection) thallium and (in a subset of patients) late functional recovery evaluated by a follow-up echocardiogram at rest. Twenty-two patients with angiographically documented coronary artery disease and regional dysfunction in resting conditions (average left ventricular ejection fraction 43 ± 8%) were studied by echocardiography. All patients underwent a dipyridamole-echocardiographic test (up to 0.84 mg/kg over 10 minutes) and a delayed planar thallium study. A 13-segment model was used for both techniques. A score index ranging from 1 (normokinesia) to 4 (dyskinesia) was used for echocardiography. Thallium-201 activity was expressed in each segment as the percentage of maximal activity in the corresponding view. After dipyridamole, the wall motion score was assigned to each segment in resting conditions and at peak hyperkinesia before possible mechanical signs of ischemia. A segment was considered viable when there was a regional activity >55% of peak thallium and when a resting dyssynergy (echocardiographic score ≥2) showed an improvement of ≥1 grade by dipyridamole. In all, 80 basally asynergic segments were scored. Dipyridamole and thallium had concordant results in 21 of 26 thallium-viable and 52 of 54 thallium-necrotic segments. The 23 segments viable by dipyridamole had a higher thallium score than did the 57 necrotic by dipyridamole (73 ± 9 vs 42 ± 9; p <0.01). In a subset of 15 patients, a follow-up echocardiogram at rest was obtained at 3.4 ± 2.7 months after the initial study. A significant functional recovery (improvement of ≥1 grade) was found in 15 of 19 segments with and only 5 of 39 without dipyridamole-induced improvement (79 vs 13%; p <0.01). These observations suggest that dipyridamole-induced recovery in the contractile function of basally asynergic segments (possibly linked to the inotropic effect of increased flow) identifies areas with myocardial viability.

AB - In patients with coronary artery disease and left ventricular impairment, the distinction between ventricular dysfunction due to myocardial fibrosis and postischemic, viable, although dyssynergic, myocardium has important clinical implications. Experimental studies have shown that dipyridamole can increase myocardial function in stunned segments, outlining a potential role of dipyridamole-induced functional recovery as an ultrasonic marker of myocardial viability. The aim of this study was to assess whether the increase of regional left ventricular function early during dipyridamole infusion in basally asynergic segments could identify viable myocardium recognized by rest injected, delayed (>14 hours from tracer injection) thallium and (in a subset of patients) late functional recovery evaluated by a follow-up echocardiogram at rest. Twenty-two patients with angiographically documented coronary artery disease and regional dysfunction in resting conditions (average left ventricular ejection fraction 43 ± 8%) were studied by echocardiography. All patients underwent a dipyridamole-echocardiographic test (up to 0.84 mg/kg over 10 minutes) and a delayed planar thallium study. A 13-segment model was used for both techniques. A score index ranging from 1 (normokinesia) to 4 (dyskinesia) was used for echocardiography. Thallium-201 activity was expressed in each segment as the percentage of maximal activity in the corresponding view. After dipyridamole, the wall motion score was assigned to each segment in resting conditions and at peak hyperkinesia before possible mechanical signs of ischemia. A segment was considered viable when there was a regional activity >55% of peak thallium and when a resting dyssynergy (echocardiographic score ≥2) showed an improvement of ≥1 grade by dipyridamole. In all, 80 basally asynergic segments were scored. Dipyridamole and thallium had concordant results in 21 of 26 thallium-viable and 52 of 54 thallium-necrotic segments. The 23 segments viable by dipyridamole had a higher thallium score than did the 57 necrotic by dipyridamole (73 ± 9 vs 42 ± 9; p <0.01). In a subset of 15 patients, a follow-up echocardiogram at rest was obtained at 3.4 ± 2.7 months after the initial study. A significant functional recovery (improvement of ≥1 grade) was found in 15 of 19 segments with and only 5 of 39 without dipyridamole-induced improvement (79 vs 13%; p <0.01). These observations suggest that dipyridamole-induced recovery in the contractile function of basally asynergic segments (possibly linked to the inotropic effect of increased flow) identifies areas with myocardial viability.

UR - http://www.scopus.com/inward/record.url?scp=0026736787&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026736787&partnerID=8YFLogxK

U2 - 10.1016/0002-9149(92)90545-A

DO - 10.1016/0002-9149(92)90545-A

M3 - Article

C2 - 1519518

AN - SCOPUS:0026736787

VL - 70

SP - 703

EP - 710

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 7

ER -